ATE336251T1 - Verfahren und zusammensetzungen zum zuverlässigen erreichen eines günstigen serumtestosteronspiegels - Google Patents

Verfahren und zusammensetzungen zum zuverlässigen erreichen eines günstigen serumtestosteronspiegels

Info

Publication number
ATE336251T1
ATE336251T1 AT04075804T AT04075804T ATE336251T1 AT E336251 T1 ATE336251 T1 AT E336251T1 AT 04075804 T AT04075804 T AT 04075804T AT 04075804 T AT04075804 T AT 04075804T AT E336251 T1 ATE336251 T1 AT E336251T1
Authority
AT
Austria
Prior art keywords
achievement
reliably
compositions
methods
serum testosterone
Prior art date
Application number
AT04075804T
Other languages
German (de)
English (en)
Inventor
Doris Huebler
Sabine Fricke
Jan-Peter Ingwersen
Wilhelm Kuhnz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32748728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE336251(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE336251T1 publication Critical patent/ATE336251T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT04075804T 2003-03-14 2004-03-15 Verfahren und zusammensetzungen zum zuverlässigen erreichen eines günstigen serumtestosteronspiegels ATE336251T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300399 2003-03-14

Publications (1)

Publication Number Publication Date
ATE336251T1 true ATE336251T1 (de) 2006-09-15

Family

ID=32748728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04075804T ATE336251T1 (de) 2003-03-14 2004-03-15 Verfahren und zusammensetzungen zum zuverlässigen erreichen eines günstigen serumtestosteronspiegels

Country Status (39)

Country Link
US (2) US7718640B2 (OSRAM)
EP (2) EP1457208B9 (OSRAM)
JP (1) JP4680891B2 (OSRAM)
KR (2) KR20080096717A (OSRAM)
CN (2) CN101884639A (OSRAM)
AR (1) AR043603A1 (OSRAM)
AT (1) ATE336251T1 (OSRAM)
AU (1) AU2004218893B2 (OSRAM)
BR (2) BR122017008910A8 (OSRAM)
CA (1) CA2518910C (OSRAM)
CL (1) CL2004000527A1 (OSRAM)
CO (1) CO5700724A2 (OSRAM)
CR (1) CR7999A (OSRAM)
CY (1) CY1105794T1 (OSRAM)
DE (1) DE602004001893T2 (OSRAM)
DK (1) DK1457208T3 (OSRAM)
EA (1) EA011568B1 (OSRAM)
EC (1) ECSP056095A (OSRAM)
ES (1) ES2271772T3 (OSRAM)
HR (1) HRP20050781B1 (OSRAM)
IL (1) IL170473A (OSRAM)
IS (1) IS2565B (OSRAM)
JO (1) JO2505B1 (OSRAM)
ME (2) MEP14508A (OSRAM)
MX (1) MXPA04002395A (OSRAM)
NO (1) NO335179B1 (OSRAM)
NZ (1) NZ542321A (OSRAM)
PE (1) PE20041065A1 (OSRAM)
PL (1) PL1457208T3 (OSRAM)
PT (1) PT1457208E (OSRAM)
RS (1) RS51537B (OSRAM)
RU (2) RU2354381C2 (OSRAM)
SA (1) SA04250040B1 (OSRAM)
SI (1) SI1457208T1 (OSRAM)
TW (1) TWI345976B (OSRAM)
UA (1) UA82510C2 (OSRAM)
UY (1) UY28231A1 (OSRAM)
WO (1) WO2004080383A2 (OSRAM)
ZA (2) ZA200508313B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050152858A1 (en) * 2003-07-11 2005-07-14 Isp Investments Inc. Solubilizing agents for active or functional organic compounds
WO2006113505A2 (en) 2005-04-15 2006-10-26 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
AU2014200332B2 (en) * 2008-04-28 2016-10-06 Diurnal Limited Lipid composition
WO2010094623A1 (en) 2009-02-18 2010-08-26 Bayer Schering Pharma Aktiengesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20130178454A1 (en) * 2011-11-17 2013-07-11 Shalender Bhasin Combination of testosterone and ornithine decarboxylase (odc) inhibitors
EP2833944A4 (en) 2012-04-06 2016-05-25 Antares Pharma Inc ADMINISTRATION OF TESTOSTERONE COMPOSITIONS BY NEEDLE-SUPPORTED NOZZLE INJECTION
AR091006A1 (es) * 2012-05-09 2014-12-30 Univ Western Health Sciences Formulaciones de testosterona proliposomal
US20140171918A1 (en) * 2012-12-14 2014-06-19 Bioject, Inc. Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
PT2953667T (pt) * 2013-02-11 2020-01-28 Antares Pharma Inc Dispositivo de injeção a jato auxiliado por agulha tendo força de gatilho reduzida
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
EP3033138A4 (en) * 2013-08-12 2017-03-29 Nanomedical Systems Inc. Device and method for sustained release of low water solubility therapeutic agent in solubilizer
EA201692083A1 (ru) 2014-04-16 2017-03-31 Вейкс-Фарма Гмбх Фармацевтическая композиция для ветеринарии и ее применение
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105056115A (zh) * 2015-08-05 2015-11-18 成都市飞龙水处理技术研究所 一种治疗化脓性睾丸炎的内服药物及其制备方法
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US11311554B2 (en) 2018-04-04 2022-04-26 Slayback Pharma Llc Pharmaceutical compositions of testosterone
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
KR102051808B1 (ko) * 2018-07-23 2019-12-04 주식회사 종근당 테스토스테론 운데카노에이트를 포함하는 안정한 약제학적 조성물
WO2020118437A1 (en) * 2018-12-14 2020-06-18 Acerus Biopharma Inc. Active ester derivatives of testosterone, compositions and uses thereof
US11564933B2 (en) 2019-04-12 2023-01-31 Tolmar, Inc. Methods of treating testosterone deficiency
EP4038147A4 (en) * 2019-10-03 2024-02-07 Caren Pharmaceuticals, Inc. COMBINATORIAL HORMONAL THERAPIES AND FORMULATIONS
CA3184810A1 (en) * 2020-06-11 2021-12-16 Ash Stevens, Llc Monomeric and oligomeric compound embodiments as contraceptives and therapies and methods of making and using the same
US12257257B2 (en) * 2023-07-27 2025-03-25 Lipocine, Inc. Testosterone dodecanoate compositions and methods
KR20250176964A (ko) * 2024-06-13 2025-12-22 주식회사 종근당 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 주사용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164520A (en) 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
US4181721A (en) 1975-10-27 1980-01-01 Schering Aktiengesellschaft Depot preparations in an oily, unsaturated solution for intramuscular injection
DE2548413A1 (de) 1975-10-27 1977-04-28 Schering Ag Depotpraeparate in oeliger ungesaettigter loesung zur intramuskulaeren injektion
GB1567515A (en) 1976-05-28 1980-05-14 Akzo Nv Esters of testo-sterone and 5 -dihydro-testosterone
NL7711916A (nl) 1977-10-29 1979-05-02 Akzo Nv Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
US4242863A (en) * 1978-03-16 1981-01-06 Caterpillar Tractor Co. Dual phase fuel vaporizing combustor
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5364632A (en) 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CN1102095A (zh) 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9608719D0 (en) 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
SE9700642D0 (sv) 1997-02-24 1997-02-24 Kronvall Stefan Med Ab Medel och sätt för förebyggande och behandling av det metabola syndromet
KR100499438B1 (ko) * 1997-12-03 2005-07-07 머크 앤드 캄파니 인코포레이티드 수소화 피마자유를 함유하는 지속성 주사제
AU4513099A (en) 1998-06-19 2000-01-10 Akzo Nobel N.V. Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone)
RU2216546C2 (ru) 1998-06-19 2003-11-20 Акцо Нобель Н.В. СОЕДИНЕНИЕ (7α,17β)-7-МЕТИЛ-17-[(1-ОКСОУНДЕЦИЛ)ОКСИ]ЭСТР-4-ЕН-3-ОН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, НАБОР ДЛЯ МУЖСКОЙ КОНТРАЦЕПЦИИ
RU2246296C2 (ru) 1999-04-01 2005-02-20 Акцо Нобель Н.В. Композиция, включающая ундеканоат тестостерона и касторовое масло
HK1049442B (en) * 2000-02-15 2007-06-15 Bayer Schering Pharma Aktiengesellschaft Male contraceptive formulation comprising norethisterone and testosterone undecanoate
MXPA03001147A (es) 2000-08-23 2003-10-06 Akzo Nobel Nv Nueva formulacion de ester de testosterona para uso humano.

Also Published As

Publication number Publication date
EA200501819A1 (ru) 2006-06-30
US20090156564A1 (en) 2009-06-18
RU2007118196A (ru) 2008-11-27
ME00149B (me) 2010-06-10
AU2004218893B2 (en) 2008-10-09
TWI345976B (en) 2011-08-01
SI1457208T1 (sl) 2007-02-28
AU2004218893A1 (en) 2004-09-23
HRP20050781B1 (hr) 2015-04-10
ZA200508313B (en) 2007-04-25
EP1457208B1 (en) 2006-08-16
PE20041065A1 (es) 2005-02-24
JO2505B1 (en) 2009-10-05
WO2004080383B1 (en) 2005-05-06
UA82510C2 (uk) 2008-04-25
RS51537B (sr) 2011-06-30
NO20054711D0 (no) 2005-10-13
CN1761469A (zh) 2006-04-19
US8338395B2 (en) 2012-12-25
KR20080096717A (ko) 2008-10-31
UY28231A1 (es) 2004-11-08
NZ542321A (en) 2008-05-30
AR043603A1 (es) 2005-08-03
HK1069325A1 (en) 2005-05-20
US20050032762A1 (en) 2005-02-10
US7718640B2 (en) 2010-05-18
IS2565B (is) 2009-12-15
PL1457208T3 (pl) 2007-01-31
RU2354381C2 (ru) 2009-05-10
TW200511997A (en) 2005-04-01
EP1457208B9 (en) 2006-10-25
CA2518910A1 (en) 2004-09-23
DK1457208T3 (da) 2006-12-11
BRPI0400214A8 (pt) 2023-05-09
MEP14508A (en) 2010-06-10
PT1457208E (pt) 2007-01-31
BRPI0400214A (pt) 2005-02-09
BR122017008910A8 (pt) 2023-05-09
KR100882378B1 (ko) 2009-02-05
WO2004080383A2 (en) 2004-09-23
IS8069A (is) 2005-10-12
CN101884639A (zh) 2010-11-17
CL2004000527A1 (es) 2005-02-18
CN1761469B (zh) 2019-05-17
SA04250040B1 (ar) 2008-01-07
WO2004080383A3 (en) 2005-03-31
EP1743646A3 (en) 2007-03-28
JP2006520377A (ja) 2006-09-07
JP4680891B2 (ja) 2011-05-11
BR122017008910A2 (OSRAM) 2005-02-09
ZA200700046B (en) 2008-04-30
ECSP056095A (es) 2006-03-01
NO20054711L (no) 2005-12-13
IL170473A (en) 2010-05-31
KR20050109561A (ko) 2005-11-21
CA2518910C (en) 2009-09-08
CY1105794T1 (el) 2011-02-02
HRP20050781A2 (en) 2005-10-31
DE602004001893T2 (de) 2007-03-15
EA011568B1 (ru) 2009-04-28
DE602004001893D1 (de) 2006-09-28
MXPA04002395A (es) 2004-09-20
CR7999A (es) 2006-05-29
NO335179B1 (no) 2014-10-13
EP1457208A1 (en) 2004-09-15
RU2005131724A (ru) 2006-05-10
RS20050702A (sr) 2007-06-04
ES2271772T3 (es) 2007-04-16
EP1743646A2 (en) 2007-01-17
CO5700724A2 (es) 2006-11-30

Similar Documents

Publication Publication Date Title
DE602004001893D1 (de) Verfahren und Zusammensetzungen zum zuverlässigen Erreichen eines günstigen Serumtestosteronspiegels
EP1793745A4 (en) PROCESSES AND DEVICES FOR SEIZING AND ASSESSING FABRICS
DE60327035D1 (de) Verfahren zur Erstellung eines Modells zur Simulation des multi-lithologischen Befüllung eines Sediment-Beckens
ATE544861T1 (de) Verfahren und zusammensetzungen für den ausdruck eines polynukleotid von interesse
ATE369396T1 (de) Polymerzusammensetzungen und verfahren zum herstellen von rohren daraus
DE502005000527D1 (de) Verfahren und Vorrichtung zum Bestimmen eines Wendezeitpunktes eines Gargutes
DE602005004280D1 (de) Verfahren zum ziehen von sic-einkristallen und sic-einkristall
DE50304673D1 (de) Strömungsmaschine und Verfahren zum Herstellen eines Leitgitters
DE502004006428D1 (de) Verfahren zum abbremsen eines fahrzeugs
DE602005000732D1 (de) Reinigungszusammensetzung für Halbleiterkomponente und Verfahren zur Herstellung eines Halbleitergeräts
DE50303236D1 (de) Verfahren und vorrichtung zum verhindern eines unbeabsichtigten wegrollens eines stillstehenden fahrzeuges
DE102004044717B8 (de) Verfahren und Kit zur Kalibrierung eines Photolumineszenzmesssystems
DE60201243D1 (de) Verfahren zum Auswerten des degradierten Zustands eines Kohlenwasserstoffadsorbant
DE60326196D1 (de) Vorrichtungen und Verfahren zur Ermittlung der N-beste Ketten eines Automaten
DE602006009890D1 (de) Verfahren zum Hinzufügen eines Effekts und Vorrichtung zum Hinzufügen eines Effekts
DE602005017898D1 (de) Verfahren und kit zum nachweis von histamin
ATE440604T1 (de) Verfahren zum evaluieren und behandeln von krebs
EP1778878A4 (en) METHODS AND COMPOSITIONS FOR THE DETECTION OF RHINOVIRUS
ATE393388T1 (de) Verfahren zum detektieren und entfernen von fremdkörpern
DE502005003865D1 (de) Vorrichtung und verfahren zur darstellung der wirkrichtung eines arbeitsmittels
DE602004014412D1 (de) Verfahren und vorrichtung zum programmieren eines
EP1500621A4 (en) ELEVATOR / LIFT MECHANISM FOR ELEVATOR AND METHOD THEREOF
DE502007007126D1 (de) Verfahren und vorrichtung zum begrenzen von stelleingriffen eines fahrzeugreglers
DE60322829D1 (de) Verfahren zum Prüfen
DE502004001226D1 (de) Verfahren zum Betrieb eines Schubmaststaplers und Schubmaststapler zur Durchführung des Verfahrens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1457208

Country of ref document: EP

EEFA Change of the company name